BioWorld MedTech

Sep. 18, 2015

View Archived Issues

India/China Talent War: Brain drain or research exchange? China, India sharing and competing

Inside the Beltway: CMS proposes to retain CED for PET imaging for bone metastases

Agreements/contracts: Sequenom gets coverage for prenatal diagnostics

World in Review: Qiagen reports launch of careHPV, CE mark for self-collection claim

Court Report: Medical diagnostics chairman charged in stock manipulation scheme

Products

People in Places

Briefly noted

MDD's Diagnostics Extra

China ripe with opportunity: Ativa Medical brings in $15M in Series B equity funding

The emerging health care market in China has been a significant driver in Ativa Medical (St. Paul, Minn.) closing its Series B funding round. Read More

Clinicians urged to PICC up Guide: Researchers create 'MAGIC' guide to using devices for vascular access

Today's news in brief

BioWorld

BioWorld briefs for April 17, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for April 17, 2025.

Ouch! Tariffs hit med tech harder than expected

BioWorld MedTech

First quarter earnings reports from Johnson & Johnson and Abbott Laboratories provided some surprising insights into the likely hit med-tech companies will...

Post-Pfizer dropout, Lilly Achieves GLP-1 win in phase III

BioWorld

Days after Pfizer Inc. pulled the plug on its oral GLP-1 candidate danuglipron, Eli Lilly and Co. aired positive top-line data from the phase III trial called...

ADPD 2025: Novel treatment modalities in neurodegenerative disorders

BioWorld Science

The current treatment strategies for neurodegenerative diseases focus on targeting Aβ in Alzheimer’s disease (AD), α-synuclein aggregates in Parkinson’s disease...